| Literature DB >> 31869358 |
Przemysław Kunert1, Anna Podgórska1, Tomasz Andrzej Dziedzic1, Andrzej Marchel1.
Abstract
PURPOSE: The aim of this study was to analyze the utility of various preoperative electrophysiological tests of the facial nerve CNVII in predicting CNVII function after vestibular schwannoma surgery.Entities:
Mesh:
Year: 2019 PMID: 31869358 PMCID: PMC6927592 DOI: 10.1371/journal.pone.0226607
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient characteristics (n = 176).
| Gender | |
| Women | 106 (60%) |
| Men | 70 (40%) |
| Age (years) | |
| Min | 18 |
| Max | 74 |
| Mean | 46 |
| Symptom duration (months) | |
| Min | 1 |
| Max | 360 |
| Mean | 46 |
| CNVII function before surgery | |
| No paresis (HB grade I) | 144 (82%) |
| Any paresis (HB grades II-VI) | 32 (18%) |
| CNV before surgery | |
| No symptoms | 128 (73%) |
| Any symptom | 48 (27%) |
| Min | 8 |
| Max | 72 |
| Mean | 30 |
| Min | 0.2 |
| Max | 66 |
| Mean | 14 |
| Grade I | 0 (0%) |
| Grade II | 10 (6%) |
| Grade IIIA | 19 (11%) |
| Grade IIIB | 27 (15%) |
| Grade IVA | 30 (17%) |
| Grade IVB | 90 (51%) |
| Anterior | 83 (47%) |
| Anteromedial | 57 (32%) |
| Anterolateral | 33 (19%) |
| Inferior | 1 (0.6%) |
| Inside the tumor | 1 (0.6%) |
| CNVII not identified | 1 (0.6%) |
The tumor size was assumed to be the maximum extrameatal diameter of the tumor. The tumor volume was calculated according to the formula: 4/3 x 3.14 x A x B x C x 1/8, where A, B, and C refer to the dimensions of the tumor in 3 planes. Tumor grade was classified according to the scale proposed by Samii: grade T1—purely intrameatal, grade T2—intra-extrameatal, grade T3a—filling the cerebellopontine cistern, grade T3b—reaching the brain stem, grade T4a—compressing the brain stem, grade T4b—severely dislocating the brain stem and compressing the fourth ventricle (Matthies and Samii 1997). The facial nerve displacement pattern was classified intraoperatively as follows: anterior, anteromedial, anterolateral, posterior, or inside the tumor. HB—House-Brackmann grading system. CNVII—facial nerve. CNV—trigeminal nerve.
Results of preoperative electrophysiological testing of CNVII and correlations of preoperative electrophysiological testing results with selected factors.
| CNVII before surgery | CNV before surgery | Tumor grade | Tumor size | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | No paresis | Any paresis | No symptoms | Any symptoms | Samii I–III | Samii IV | ≤ 30 mm | > 30mm | |
| AD-CNVII (+) | 42 (24%) | 30 (21%) | 12 (38%) | 33 (26%) | 9 (19%) | 18 (32%) | 24 (20%) | 26 (28%) | 16 (20%) |
| AD-CNVII (-) | 134 (76%) | 114 (79%) | 20 (62%) | 95 (74%) | 39 (81%) | 38 (68%) | 96 (80%) | 68 (72%) | 66 (80%) |
| D-CNV (+) | 17 (10%) | 9 (6%) | 8 (26%) | 7 (6%) | 10 (26%) | 0 (0%) | 17 (15%) | 4 (4%) | 13 (17%) |
| D-CNV (-) | 155 (88%) | 132 (94%) | 23 (74%) | 119 (94%) | 36 (78%) | 56 (100%) | 99 (85%) | 90 (96%) | 65 (83%) |
| D-CNV doubtful | 4 (2%) | ||||||||
| D-BR (+) | 112 (64%) | 88 (66%) | 24 (83%) | 80 (66%) | 32 (78%) | 31 (57%) | 81 (74%) | 58 (64%) | 54 (75%) |
| D-BR (-) | 51 (29%) | 46 (34%) | 5 (17%) | 42 (34%) | 9 (22%) | 23 (43%) | 28 (26%) | 33 (36%) | 18 (25%) |
| D-BR doubtful | 13 (7%) | ||||||||
| A-EMG (+) | 125 (71%) | 98 (68%) | 27 (84%) | 89 (70%) | 36 (75%) | 35 (62%) | 90 (75%) | 64 (68%) | 61 (74%) |
| A-EMG (-) | 51 (29%) | 46 (32%) | 5 (16%) | 39 (30%) | 12 (25%) | 21 (38%) | 30 (25%) | 30 (32%) | 21 (26%) |
AD-CNVII = Axonal degeneration of CNVII, D-CNV = Damage of CNV (conduction disturbances of an afferent pattern of blink reflex), D-BR = Conduction disturbance of the short latency pathway of the blink reflex, A-EMG = Abnormal EMG (any notable changes).
*In a few cases, some of the electrophysiological testing results were unclear and were thus excluded from the analysis.
The Spearman rho correlation analysis of electrophysiological changes with pre- and intraoperative factors.
| AD-CNVII | D-CNV | D-BR | A-EMG | ||
|---|---|---|---|---|---|
| Age | rho | .001 | .125 | .027 | -.017 |
| p | .992 | .103 | .735 | .824 | |
| N | 176 | 172 | 163 | 176 | |
| Gender | rho | -.074 | .019 | .049 | -.018 |
| p | .331 | .804 | .537 | .809 | |
| N | 176 | 172 | 163 | 176 | |
| Symptom duration | rho | -.092 | .064 | -.001 | -.034 |
| p | .230 | .407 | .988 | .654 | |
| N | 173 | 169 | 160 | 173 | |
| CNV disturbances of any type | rho | -.073 | .240 | .117 | .054 |
| p | .333 | .138 | .479 | ||
| N | 176 | 172 | 163 | 176 | |
| CNVII paresis before surgery | rho | .167 | .253 | .142 | .145 |
| p | .071 | .055 | |||
| N | 176 | 172 | 163 | 176 | |
| Tumor grade | rho | -.106 | .257 | .165 | .118 |
| p | .161 | .120 | |||
| N | 176 | 172 | 163 | 176 | |
| Tumor size | rho | -.041 | .237 | .159 | .137 |
| p | .586 | .071 | |||
| N | 176 | 172 | 163 | 176 | |
| Tumor volume | rho | -.024 | .15 | .070 | .070 |
| p | .749 | .374 | .355 | ||
| N | 176 | 172 | 163 | 176 | |
| CNVII displacement pattern | rho | .086 | .097 | .050 | -.019 |
| p | .259 | .208 | .526 | .799 | |
| N | 174 | 170 | 161 | 174 |
* p < 0.05 –in bold text
Evolution of CNVII function throughout the perioperative period and at late follow-up.
| Before surgery | Continuity preservation of CNVII during surgery | Early outcome | Late outcome | ||||
|---|---|---|---|---|---|---|---|
| HB grade I | 144 (82%) | Preserved—157 (89%) | 13 (7%) | Satisfactory 37% | 57 (32%) | Satisfactory 74% | |
| HB grade II | 25 (14%) | Any paresis 18% | 21 (12%) | 45 (26%) | |||
| HB grade III | 2 (1%) | 32 (18%) | 28 (16%) | ||||
| HB grade IV | 2 (1%) | 67 (38%) | Not satisfactory 63% | 17 (10%) | Not satisfactory 26% | ||
| HB grade V | 0 (0%) | 22 (13%) | 8 (4%) | ||||
| HB grade VI | 3 (2%) | Not preserved -19 (11%) | 21 | 21 | |||
Facial nerve (CNVII) function was evaluated according to the House-Brackmann (HB) grading scale. A satisfactory outcome included no or mild paresis until normal symmetry at rest and eyelids could close normally (i.e. HB grades I–III).
*In cases with CNVII interruption during tumor removal, repair procedures such as ‘loco operationis’ or extratemporal anastomosis were performed. However, the results of these procedures were not taken into account in this study. Patients with interrupted facial nerves were assessed at late follow-up as HB grade VI, regardless of whether they had satisfactory anastomosis results, as this could interfere with the evaluation of spontaneous CNVII function recovery.
Correlation of electrophysiological test results and other variables with unsatisfactory CNVII function at different times.
| Facial nerve function | ||||
|---|---|---|---|---|
| Loss of continuity during surgery N° 19 | Unsatisfactory early outcome (HB IV–VI) N° 110 | Unsatisfactory late outcome (HB IV–VI) N° 46 | ||
| AD-CNVII /+/ (N° 42) | 5/42 (12%) | 30/42 (71%) | 14/42 (33%) | |
| AD-CNVII /-/ (N° 134) | 14/134 (10%) | 80/134 (60%) | 32/134 (24%) | |
| D-CNV /+/ (N° 17) | 2/17 (12%) | 16/17 (94%) | 9/17 (53%) | |
| D-CNV /-/ (N° 155) | 17/155 (11%) | 90/155 (58%) | 37/155 (24%) | |
| D-BR /+/ (N° 112) | 13/112 (12%) | 73/112 (65%) | 36/112 (32%) | |
| D-BR /-/ (N° 51) | 5/51 (10%) | 26/51 (51%) | 9/51 (18%) | |
| A-EMG /+/ (N° 125) | 15/125 (12%) | 82/125 (66%) | 39/125 (31%) | |
| A-EMG /-/ (N° 51) | 4/51 (8%) | 28/51 (55%) | 7/51 (14%) | |
| Tumor grade I–III (N° 56) | 1/56 (2%) | 25/56 (45%) | 4/56 (7%) | |
| Tumor grade IV (N° 120) | 18/120 (15%) | 85/120 (71%) | 42/120 (35%) | |
| Tumor size ≤ 30 mm (N° 94) | 5/94 (5%) | 49/94 (52%) | 12/94 (13%) | |
| Tumor size > 30 mm (N° 82) | 14/82 (17%) | 61/82 (74%) | 34/82 (41%) | |
| Tumor volume ≤ 10 ml3 (N° 88) | 3/88 (3%) | 45/88 (51%) | 11/88 (13%) | |
| Tumor volume > 10 ml3 (N° 88) | 16/88 (18%) | 65/88 (74%) | 35/88 (40%) | |
| CNVII Displacement pattern | Anterior | 8/83 (10%) | 45/83 (54%) | 16/83 (19%) |
| Anteromedial | 4/57 (7%) | 44/57 (77%) | 17/57 (30%) | |
| Anterolateral | 5/33 (15%) | 19/33 (58%) | 11/33 (33%) | |
Pearson’s R correlations of electrophysiological test results and other variables with CNVII function at different times.
| Facial nerve function | ||||
|---|---|---|---|---|
| Intraoperative continuity Preservation | Early outcome | Late outcome | ||
| AD-CNVII | R | -.020 | .115 | .126 |
| P | .792 | .130 | .097 | |
| N | 176 | 176 | 176 | |
| D-CNV | R | -.008 | .215 | .228 |
| P | .921 | |||
| N | 172 | 172 | 172 | |
| D-BR | R | -.027 | .052 | .141 |
| P | .735 | .511 | .072 | |
| N | 163 | 163 | 163 | |
| A-EMG | R | -.061 | .063 | .157 |
| P | .423 | .409 | ||
| N | 176 | 176 | 176 | |
| Tumor grade | R | -.210 | .384 | .340 |
| P | ||||
| N | 176 | 176 | 176 | |
| Tumor size | R | -.214 | .323 | .322 |
| P | ||||
| N | 176 | 176 | 176 | |
| Tumor volume | R | -.261 | .303 | .316 |
| P | ||||
| N | 176 | 176 | 176 | |
| CNVII displacement pattern | R | -.064 | .107 | .175 |
| P | .404 | .162 | ||
| N | 174 | 174 | 174 | |
* p < 0.05–in bold text
Regression analysis to assess electrophysiological changes and other factors as potential independent predictors for CNVII function after surgery.
| Dependent measure: CVNII continuity preservation. Logistic regression. | ||||
| B | p | 95% CI | ||
| Tumor volume | -.045 | .929 | .985 | |
| A-EMG | .466 | |||
| AD-CNVII | .695 | |||
| D-CNV | .707 | |||
| D-BR | .828 | |||
| Tumor grade | .059 | |||
| Tumor size | .926 | |||
| Dependent measure: CVNII function—early outcome. Linear regression. | ||||
| Beta | p | 95% CI | ||
| Tumor grade | .403 | .273 | .581 | |
| AD-CNVII | .180 | .110 | 1.031 | |
| A-EMG | -.023 | .770 | ||
| D-CNV | .072 | .340 | ||
| D-BR | -.060 | .434 | ||
| Tumor size | -.076 | .583 | ||
| Tumor volume | .066 | .481 | ||
| Dependent measure: CVNII function—late outcome. Linear regression. | ||||
| Beta | p | 95% CI | ||
| Tumor grade | .356 | .278 | .676 | |
| AD-CNVII | .164 | .061 | 1.251 | |
| A-EMG | .055 | .500 | ||
| D-CNV | .107 | .165 | ||
| D-BR | .052 | .507 | ||
| Tumor size | .107 | .448 | ||
| Tumor volume | .163 | .089 | ||
| CNVII displacement | .055 | .500 | ||
* p < 0.05 –in bold text
Correlation of the electrophysiological variables with long-term outcomes of CNVII function according to tumor grade.
| Grade I–III tumors | Grade IV tumors | |||
|---|---|---|---|---|
| HB I–III | HB IV–VI | HB I–III | HB IV–VI | |
| AD-CNVII (+) | 16 (89%) | 2 (11%) | 12 (50%) | 12 (50%) |
| AD-CNVII (-) | 36 (95%) | 2 (5%) | 66 (69%) | 30 (31%) |
| D-CNV (+) | 0 | 0 | 8 (47%) | 9 (53%) |
| D-CNV (-) | 52 (93%) | 4 (7%) | 66 (67%) | 33 (33%) |
| D-BR (+) | 27 (87%) | 4 (13%) | 49 (60%) | 32 (40%) |
| D-BR (-) | 23 (100%) | 0 | 19 (68%) | 9 (32%) |
| A-EMG (+) | 31 (89%) | 4 (11%) | 55 (61%) | 35 (39%) |
| A-EMG (-) | 21 (100%) | 0 | 23 (77%) | 7 (23%) |